18.2 Thunderclap & Acute Severe Secondary Headaches

Thunderclap Headache: Clinical Definition & Urgent Differential Diagnosis

A Thunderclap Headache (TCH) is clinically defined as an excruciating, explosive headache that peaks at maximal intensity within 60 seconds of onset. Patients frequently characterize the event as "the worst headache of my entire life" or describe feeling as though they were "struck in the back of the head with a baseball bat." TCH is a true medical emergency: approximately 20% to 25% of patients presenting with a true thunderclap headache harbor a life-threatening secondary underlying vascular etiology.

Comprehensive Differential Diagnosis of Thunderclap Headache

---

Diagnostic Evaluation of Suspected SAH: The Ottawa Rule, 6-Hour CT & LP

The Ottawa Subarachnoid Hemorrhage Rule

The Ottawa SAH Rule was prospectively validated in alert, neurologically intact adult patients (age ≥15 years) presenting with a new acute, non-traumatic headache peaking within 1 hour. It demonstrates 100% sensitivity (and ~15% specificity) for identifying subarachnoid hemorrhage. Diagnostic workup (non-contrast head CT) is mandated if ANY ONE of the following 6 criteria is met:

1. Age ≥40 years
2. Complaint of neck pain or neck stiffness
3. Witnessed loss of consciousness
4. Onset during exertion (e.g., heavy lifting, sports, sexual intercourse, Valsalva)
5. Thunderclap headache (pain peaking instantly / <1 minute)
6. Limited neck flexion on physical examination (inability to touch chin to chest)

Rule Caveat: The Ottawa rule applies only to alert patients with GCS 15. Patients with altered sensorium, focal neurologic deficits, or known prior intracranial aneurysms bypass clinical rules and proceed directly to emergency neuroimaging.

The 6-Hour Non-Contrast Head CT Rule

The timing of non-contrast head CT is the single most critical factor determining its sensitivity for subarachnoid blood:

• Within 6 Hours of Headache Onset: In landmark prospective multicenter trials (Perry et al.), a modern multi-detector (≥16-slice) non-contrast head CT performed within 6 hours of headache onset and interpreted by an experienced radiologist has a sensitivity >99.9% and a negative predictive value >99.9%.
• Guideline Mandate: If an alert, neurologically intact patient presents within 6 hours of onset and a high-quality non-contrast head CT is completely normal, aneurysmal SAH is safely ruled out. In this specific scenario, routine follow-up lumbar puncture can be safely omitted.

Beyond 6 Hours from Onset: The Mandatory Lumbar Puncture (LP)

As time elapses beyond 6 hours, CSF bulk flow clears extravasated erythrocytes, and macrophage phagocytosis lyses red blood cells, causing CT sensitivity to decline precipitously:

• 24 Hours: Sensitivity falls to ~85%–90%.
• 48 Hours: Sensitivity falls to ~75%.
• 1 Week: Sensitivity falls to ~50%.

Clinical Mandate: If a patient presents more than 6 hours after headache onset, or if the non-contrast head CT is technically inadequate, equivocal, or negative in the face of high clinical suspicion, a Lumbar Puncture (LP) is strictly mandatory.

                  SUSPECTED SAH DIAGNOSTIC CASCADE
                  
    ┌────────────────────────────────────────────────────────┐
    │ Acute Non-Traumatic Headache (Peaking within 1 Hour)   │
    └───────────────────────────┬────────────────────────────┘
                                │
                                ▼
    ┌────────────────────────────────────────────────────────┐
    │ Apply Ottawa SAH Rule (Age ≥40, Neck stiffness/pain,   │
    │ Exertion, LOC, Thunderclap, Restricted neck flexion)   │
    └───────────────────────────┬────────────────────────────┘
                                │
                ┌───────────────┴───────────────┐
                │ ALL 6 Criteria Negative?      │
                ├───────────────┬───────────────┤
                │ YES           │ NO (≥1 Met)   │
                ▼               ▼               │
     ┌─────────────────────┐  ┌─────────────────────────────────────┐
     │ SAH Safely Excluded │  │ Urgent Non-Contrast Head CT         │
     │ No CT or LP required│  └──────────────────┬──────────────────┘
     └─────────────────────┘                     │
                                 ┌───────────────┴───────────────┐
                                 │ CT Scan Timing from Onset     │
                                 ├───────────────┬───────────────┤
                                 │ ≤6 Hours      │ >6 Hours      │
                                 ▼               ▼               │
        ┌───────────────────────────────┐  ┌───────────────────────────────┐
        │ CT Negative: SAH Ruled Out    │  │ CT Negative: Sensitivity Low  │
        │ (Sens >99%; No LP needed      │  │ LP IS MANDATORY               │
        │ if intact, 3rd-gen CT)        │  │ Check Opening Pressure,       │
        └───────────────────────────────┘  │ Tube 1-4 RBCs, Xanthochromia  │
                                           └───────────────┬───────────────┘
                                                           │
                                 ┌─────────────────────────┴───────────────┐
                                 │ Xanthochromia (+) OR Persistent RBCs    │
                                 ├─────────────────────────┬───────────────┤
                                 │ Positive                │ Negative      │
                                 ▼                         ▼               │
                    ┌─────────────────────────┐  ┌─────────────────────┐
                    │ CONFIRMED SAH           │  │ SAH Ruled Out       │
                    │ • Emergent CTA Brain    │  │ Search other causes │
                    │ • Target SBP <140 mmHg  │  └─────────────────────┘
                    │ • Oral Nimodipine       │
                    │ • Emergent Neurosurgery │
                    └─────────────────────────┘

Lumbar Puncture CSF Analysis: SAH vs Traumatic Tap

Performing an LP in suspected SAH requires systematic evaluation of three critical parameters:

1. Opening Pressure: Measured in the lateral decubitus position. Normal is 10 to 20 cm H2O. Elevated in SAH (>20 cm H2O) due to obstruction of arachnoid granulations by extravasated red blood cells.
2. Serial RBC Count (Tubes 1 to 4):
   • Aneurysmal SAH: Red blood cell counts remain persistently and uniformly elevated across all tubes (tube 1 to tube 4), with <25% clearance.
   • Traumatic Tap: Puncture of an epidural or subarachnoid venule by the spinal needle causes high RBCs in tube 1 that dramatically clear or decline by >50% to 75% by tube 4.
3. Xanthochromia (The Gold Standard for Prior Bleeding):
   • Biochemical Mechanism: When erythrocytes enter the CSF in vivo, they are engulfed by arachnoid reticuloendothelial macrophages. Hemoglobin is enzymatically cleaved into oxyhemoglobin (pink/orange) and subsequently into bilirubin (yellow). The yellow pigmentation of the centrifuged CSF supernatant is termed xanthochromia.
   • Timeline: Xanthochromia requires 6 to 12 hours to develop in vivo after an initial subarachnoid hemorrhage, reaches maximal intensity at 48 hours, and persists for 2 to 4 weeks.
   • Detection: Visual inspection against a white background or, preferably, spectrophotometry (which detects light absorbance peaks at 415 nm for oxyhemoglobin and 450–460 nm for bilirubin).
   • Key Exam Distinction: In a traumatic tap, intact erythrocytes have not undergone in-vivo enzymatic conversion into bilirubin. When a traumatic tap sample is immediately centrifuged, the supernatant is crystal clear and completely negative for xanthochromia.

---

Emergency Resuscitation & Critical Care Management of SAH

Once aneurysmal SAH is identified, management focuses on preventing catastrophic early complications: rebleeding and delayed cerebral ischemia (DCI).

1. Airway, Breathing & Intensive Monitoring

• Endotracheal intubation with rapid sequence induction for patients with GCS ≤8, loss of airway protective reflexes, or acute intracranial hypertension.
• Immediate transfer to a dedicated Neurointensive Care Unit (NICU).

2. Acute Blood Pressure Control

• The Danger of Rebleeding: The incidence of aneurysmal rebleeding is highest in the first 2 to 24 hours (peak 4–10%), carrying a catastrophic case-fatality rate of 50% to 70%.
• Blood Pressure Target: Maintain Systolic Blood Pressure (SBP) <140 mm Hg (or Mean Arterial Pressure [MAP] <110 mm Hg) while maintaining adequate cerebral perfusion pressure (CPP ≥60 mm Hg).
• First-Line Antihypertensives:
  • IV Nicardipine Infusion: Titratable dihydropyridine calcium channel blocker. Start at 5 mg/h IV; titrate by 2.5 mg/h every 5 to 15 minutes up to a maximum of 15 mg/h.
  • IV Clevidipine: Ultra-short-acting lipid emulsion calcium channel blocker (1–2 mg/h, double every 90 seconds).
  • IV Labetalol: Combined alpha/beta-blocker (10–20 mg IV bolus over 2 minutes, repeatable or infused at 2–8 mg/min).
  • Agent to Avoid: Sodium nitroprusside is strictly avoided because it dilates cerebral venules, increasing intracranial blood volume and dangerously elevating ICP.

3. Prevention of Delayed Cerebral Ischemia (DCI) / Vasospasm

Cerebral vasospasm is the delayed arterial narrowing occurring 4 to 14 days post-SAH (peaking at days 7 to 10), driven by spasmogenic spasmolytic imbalance from hemoglobin breakdown products (oxyhemoglobin, endothelin-1).

• Oral Nimodipine (Guideline Mandate):
  • Dosing: 60 mg orally (or via nasogastric tube) every 4 hours for 21 consecutive days.
  • Mechanism: Lipophilic dihydropyridine calcium channel blocker that readily crosses the blood-brain barrier. It does not prevent macrovascular arterial narrowing on angiograms; rather, it provides cellular neuroprotection, prevents microvascular microthrombosis, and improves functional neurological survival.
  • BLACK BOX WARNING: Nimodipine capsules must NEVER BE ADMINISTERED INTRAVENOUSLY. If drawn up into a syringe to administer via a feeding tube, accidental IV injection causes profound refractory peripheral vasodilation, irreversible cardiogenic shock, and death. Syringes must be clearly labeled "NOT FOR IV USE."
• Maintenance of Euvolemia:
  • Historical "Triple-H therapy" (hypervolemia, hemodilution, hypertension) is obsolete. Clinical trials proved that aggressive hypervolemia increases pulmonary edema, myocardial infarction, and death without improving cerebral ischemia.
  • Modern standard: Maintain strict euvolemia with isotonic crystalloid (0.9% normal saline at 1–1.5 mL/kg/h). Avoid hypotonic fluids (D5W, 0.45% saline) which exacerbate cerebral edema.
  • Induced Hypertension: If delayed cerebral ischemia (new focal deficit or GCS decline) develops after the aneurysm has been secured, induce hypertension with IV vasopressors (norepinephrine or phenylephrine) to drive collateral cerebral blood flow.

4. Acute Hydrocephalus & Seizure Prophylaxis

• Acute Obstructive Hydrocephalus: Occurs in 20% to 30% of SAH patients due to blood clogging the arachnoid granulations or ventricular foramen of Monro. Requires emergent bedside External Ventricular Drain (EVD / ventriculostomy) placement by neurosurgery.
• Seizure Prophylaxis: A transient seizure raises ICP and precipitates aneurysm rebleeding. Short-term antiepileptic prophylaxis (e.g., Levetiracetam [Keppra] 500–1000 mg IV twice daily) is recommended during the acute peri-rupture period (discontinued after aneurysm securing unless active seizures occur).

5. Definitive Aneurysm Securing

• Emergent neurointerventional or neurosurgical evaluation within 24 hours to definitively secure the ruptured aneurysm and prevent rerupture.
• Endovascular Coiling: Platinum coils are threaded via femoral/radial catheter into the aneurysm dome, promoting thrombosis. Demonstrated lower 1-year disability and mortality compared to surgery in the International Subarachnoid Aneurysm Trial (ISAT), especially for posterior circulation and anterior communicating aneurysms.
• Surgical Clipping: Open craniotomy with microsurgical placement of a spring-loaded metallic clip across the aneurysm neck. Preferred for middle cerebral artery (MCA) bifurcations, wide-necked aneurysms, or large concurrent parenchymal hematomas requiring mass-effect evacuation.

---

High-Yield Secondary Headache Mimics: Clinical Pearls

Reversible Cerebral Vasoconstriction Syndrome (RCVS)

• Characterized by multiple, recurrent thunderclap headaches occurring over 1 to 4 weeks ("headache storms").
• Triggered by sympathetic activation (crying, sexual intercourse, straining) or exposure to vasoactive chemicals: SSRIs, SNRIs, sumatriptan, pseudoephedrine, cocaine, ecstasy, amphetamines, and cannabis.
• Cerebral angiography reveals diffuse, multifocal "string-of-beads" arterial narrowing that spontaneously resolves within 12 weeks.
• Treatment: Discontinue offending vasoactive drugs; administer oral calcium channel blockers (e.g., verapamil or nimodipine) to relieve arterial spasm.

Pituitary Apoplexy

• Acute infarction or hemorrhage into an unsuspected or known pituitary macroadenoma.
• Cardinal presentation: Sudden severe frontal or retro-orbital headache accompanied by:
  1. Bitemporal hemianopsia from compression of the overlying optic chiasm;
  2. Ophthalmoplegia (ptosis, diplopia) from lateral expansion into the cavernous sinus compressing CN III, IV, and VI;
  3. Acute secondary adrenal insufficiency: Destruction of ACTH-secreting corticotrophs produces sudden cortisol collapse, resulting in refractory hypotension, severe hyponatremia, and hypoglycemia.
• Management: Immediate administration of IV stress-dose hydrocortisone (100 mg IV bolus) to avert fatal circulatory shock. Perform urgent brain MRI and obtain emergent neurosurgical consultation for transsphenoidal surgical decompression.